P.133 Paediatric dosing of balovaptan for the treatment of the core symptoms of autism spectrum disorder: data from a Phase 2 study (aV1ation; NCT02901431)
| Autor: | Stark, F. Schaedeli, Chavanne, C., Lennon-Chrimes, S., Diack, C., Derks, M., Smith, J. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology November 2020 40 Supplement 1:S82-S83 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect